Notices. DEPARTMENT OF JUSTICE
730 words·~3 min read·
/register/2012/08/20/2012-20370·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 7020-02-P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application; SA INTL GMBH C/O., Sigma Aldrich Co., LLC Correction In notice document 2012-19191 appearing on pages 47106-47108 in the issue of Tuesday, August 7, 2012, make the following corrections: 1. On page 47106, in the third column, the document heading should appear as set forth above. 2. On page 4707, in the sixth paragraph following the table, in the eighth line of text, “September 6, 2012” should read “September 19, 2012”. [FR Doc.
C1-2012-19191 Filed 8-17-12; 8:45 am] BILLING CODE 1505-01-D DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application; Clinical Supplies Management, Inc. Correction In notice document 2012-19197 appearing on pages 47109-47110 in the issue of Tuesday, August 7, 2012, make the following corrections: 1. On page 47109, in the third column, the document heading should appear as set forth above. 2. On page 47110, in the second column, in the first full paragraph, in the eighth line of text, “September 6, 2012” should read “September 19, 2012”. [FR Doc.
C1-2012-19197 Filed 8-17-12; 8:45 am] BILLING CODE 1505-01-D DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application; Lipomed Correction In notice document 2012-19196 appearing on page 47108 in the issue of Tuesday, August 7, 2012, make the following corrections: 1. On page 47108, in the first column, the document heading should appear as set forth above. 2. On page 47108, in the second column, in the second full paragraph, in the eighth line of text, “September 6, 2012” should read “September 19, 2012”. [FR Doc.
C1-2012-19196 Filed 8-17-12; 8:45 am] BILLING CODE 1505-01-D DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application; R & D Systems, Inc. Correction In notice document 2012-19193 appearing on pages 47110-47111 in the issue of Tuesday, August 7, 2012, make the following corrections: 1. On page 47110, in the third column, the document heading should appear as set forth above. 2. On page 47110, in the fifth paragraph following the table, in the eighth line of text, “September 6, 2012” should read “September 19, 2012”. [FR Doc.
C1-2012-19193 Filed 8-17-12; 8:45 am] BILLING CODE 1505-01-D DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application; Cerilliant Corporation Correction In notice document 2012-19199 appearing on pages 47108-47109 in the issue of Tuesday, August 7, 2012, make the following corrections: 1. On page 47108, in the third column, the document heading should appear as set forth above. 2. On page 47109, in the sixth paragraph following the table, in the eighth line of text, “September 6, 2012” should read “September 19, 2012”. [FR Doc.
C1-2012-19199 Filed 8-17-12; 8:45 am] BILLING CODE 1505-01-D DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration; Almac Clinical Services, Inc. By Notice dated April 17, 2012, and published in the **Federal Register** on April 26, 2012, 77 FR 24985, Almac Clinical Services, Inc., (ACSI), 25 Fretz Road, Souderton, Pennsylvania 18964, made application by renewal to the Drug Enforcement Administration
(DEA)to be registered as an importer of the following basic classes of controlled substances: Drug Schedule Oxycodone
(9143)II Hydromorphone
(9150)II Tapentadol
(9780)II Fentanyl
(9801)II The company plans to import small quantities of the listed controlled substances in dosage form to conduct clinical trials. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and determined that the registration of Almac Clinical Services, Inc.
(ACSI)to import the basic classes of controlled substances is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA has investigated Almac Clinical Services, Inc.
(ACSI)to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: August 7, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2012-20370 Filed 8-17-12; 8:45 am]
Connectionstraces to 3
Citation graph
cites case law
Cites 3Cited by 0 across 0 sources